- Home
- OCEAW vs KRUS Comparison
OCEAW vs KRUS Comparison
Compare OCEAW & KRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- KRUS
- Stock Information
- Founded
- OCEAW N/A
- KRUS 2008
- Country
- OCEAW United States
- KRUS United States
- Employees
- OCEAW 7
- KRUS 3300
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- KRUS Restaurants
- Sector
- OCEAW Health Care
- KRUS Consumer Discretionary
- Exchange
- OCEAW Nasdaq
- KRUS Nasdaq
- Market Cap
- OCEAW N/A
- KRUS 627.5M
- IPO Year
- OCEAW 2021
- KRUS 2019
- Fundamental
- Price
- OCEAW $0.02
- KRUS $58.42
- Analyst Decision
- OCEAW
- KRUS Buy
- Analyst Count
- OCEAW 0
- KRUS 9
- Target Price
- OCEAW N/A
- KRUS $74.67
- AVG Volume (30 Days)
- OCEAW N/A
- KRUS 407.7K
- Earning Date
- OCEAW N/A
- KRUS 04-08-2025
- Dividend Yield
- OCEAW N/A
- KRUS N/A
- EPS Growth
- OCEAW N/A
- KRUS N/A
- EPS
- OCEAW N/A
- KRUS N/A
- Revenue
- OCEAW N/A
- KRUS $258,444,000.00
- Revenue This Year
- OCEAW N/A
- KRUS $19.94
- Revenue Next Year
- OCEAW N/A
- KRUS $21.13
- P/E Ratio
- OCEAW N/A
- KRUS N/A
- Revenue Growth
- OCEAW N/A
- KRUS 21.37
- 52 Week Low
- OCEAW N/A
- KRUS $40.03
- 52 Week High
- OCEAW N/A
- KRUS $121.99
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- KRUS 55.83
- Support Level
- OCEAW N/A
- KRUS $45.71
- Resistance Level
- OCEAW N/A
- KRUS $57.84
- Average True Range (ATR)
- OCEAW 0.00
- KRUS 5.12
- MACD
- OCEAW 0.00
- KRUS 1.72
- Stochastic Oscillator
- OCEAW 0.00
- KRUS 96.94
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
About KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.